cipaglucosidase alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cipaglucosidase alfa, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18 [Phase 3]